...VGX (formerly Viral Genomix Inc.) received a worldwide non-exclusive license to INO's DNA delivery technology for intratumoral electroporation...

...Nitrothiazolyl-salicylamide compound Ph II (C ) Schering-Plough SCH 503034 HCV NS3 protease inhibitor Ph II Viral Genomix...